Publication | Closed Access

Impact of sarcopenia indexes on survival and severe immune acute toxicity in metastatic non-small cell lung cancer patients treated with PD-1 immune checkpoint inhibitors

Cancer ImmunosurveillanceSarcopenia IndexesMedicineImmunologyBronchial NeoplasmImmune Checkpoint InhibitorCancer TreatmentLung CancerOncologyRadiation OncologyTumor Microenvironment